Curative Conversion of Metastatic Gastric Cancer After Pembrolizumab-Trastuzumab-Based Therapy in a PD-L1-Negative, HER2-Positive Patient: A Case Report and Literature Review. MJCR 2026, 1 (1), 30-38. https://doi.org/10.64913/mmrmjcr.v1i1.21.